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Abstract
The major facilitator superfamily (MFS) effluxers are prominent
mediators of antimicrobial resistance. The biochemical characteri-
zation of MFS proteins is hindered by their complex membrane
environment that makes in vitro biochemical analysis challenging.
Since the physicochemical properties of proteins drive the fitness
of an organism, we posed the question of whether we could
reverse that relationship and derive meaningful biochemical
parameters for a single protein simply from fitness changes it
confers under varying strengths of selection. Here, we present a
physiological model that uses cellular fitness as a proxy to predict
the biochemical properties of the MFS tetracycline efflux pump,
TetB, and a family of single amino acid variants. We determined
two lumped biochemical parameters roughly describing Km and
Vmax for TetB and variants. Including in vivo protein levels into our
model allowed for more specified prediction of pump parameters
relating to substrate binding affinity and pumping efficiency for
TetB and variants. We further demonstrated the general utility of
our model by solely using fitness to assay a library of tet(B) vari-
ants and estimate their biochemical properties.
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Introduction
Determining the link between protein function and fitness is qualita-
tively simple to understand as the fitness of an organism is depen-
dent on proteins encoded by the genome. However, even the
modestly sized genome of Escherichia coli consists of thousands of
genes making deconvolution of protein changes and their effects on
fitness a challenging problem (Blattner et al, 1997). Under strong
selection conditions, the complexity of this problem can be
decreased by tightly linking the performance of a single gene
product to fitness, allowing for quantitative understanding of
protein function and organismal fitness (Dean et al, 1986; Coun˜ago
et al, 2006; Walkiewicz et al, 2012). Typically, well-behaved
proteins whose function is strongly correlated to organismal fitness
are used to study this link as their biochemical properties can be
readily measured in vitro. Such model proteins include TEM-1
b-lactamase, dihydrofolate reductase, and adenylate kinase (Wang
et al, 2002; Coun˜ago et al, 2006; Weinreich et al, 2006; Pen˜a et al,
2010; Jacquier et al, 2013; Rodrigues et al, 2016). These advances
have provided a greater understanding into how the physicochemical
properties of a protein relate to fitness and allow investigators to
explore the role of fitness landscapes in adaptive evolution (Weinreich
et al, 2006; Dean & Thornton, 2007; Walkiewicz et al, 2012; Harms &
Thornton, 2013; Meini et al, 2015; Palmer et al, 2015).
Implicit in the idea that the in vitro properties of a protein can
be used to predict fitness (physicochemical properties ? pheno-
type) is the notion that fitness over a range of selection conditions
could also be used to estimate the biochemical properties of a
protein whose in vitro characterization is difficult or unknown
(phenotype ? physicochemical properties). For this study, we
define fitness as the growth rate of the cells in exponential phase
and the fitness function to be the growth rate of cells as a function
of selection strength. We previously reported the development of a
mathematical model that predicts the fitness of an organism at
selective conditions from the in vitro physicochemical properties
of a tetracycline resistance protein, TetX2, and a family of variants
(Walkiewicz et al, 2012). During exposure to minocycline (MCN),
the performance of TetX2 is tightly linked to the fitness of those
cells. Using in vitro physicochemical properties and in vivo protein
expression measurements, the model was able to predict the shape
of the fitness function curves. Here, we utilize the fundamental
reversibility of the TetX2 model and present a new in vivo model
capable of determining relative biochemical properties of an efflux
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transporter from fitness without the need for a priori in vitro
protein analysis.
Integral membrane proteins are difficult to characterize using
classical in vitro biochemical techniques as they are challenging
to express, purify, and often require recapitulation of the
membrane system for the reconstitution of activity. Analysis of
this protein class, thus, provides an excellent opportunity for
evaluation of our ability to derive useful biochemical properties
from a fitness function. As a model system, we used the tetracy-
cline resistance efflux pump tet(B) to examine whether growth
rates of bacteria carrying a variant allele over a range of selection
strength and an appropriate model can be used to determine
physicochemical parameters such as substrate binding rate (k1),
and pumping efficiency (r). TetB is a 12-transmembrane alpha
helical protein, which traverses the inner membrane of Gram-
negative bacteria and uses the proton motive force to efflux
members of the tetracycline family of antibiotics including, tetra-
cycline (TET), doxycycline (DOX), and MCN in exchange for H+.
TetB is a member of the major facilitator superfamily (MFS) of
transporters, the largest class of secondary transporters responsi-
ble for a wide variety of physiological processes such as: cell
homeostasis, nutrient import, and toxin export (Pao et al, 1998;
Yan, 2013). In addition to TetB, there are many other MFS trans-
porters, which contribute to single and multidrug resistance in a
wide variety of pathogens and their thorough characterization is
of great interest (Fluman & Bibi, 2009; Alegre et al, 2016).
Despite the low percentage of protein sequence similarity among
MFS transporters, their overall structure is largely conserved with
a general understanding of how specific regions of the transporter
contribute to substrate binding and/or pumping efficiency (Yan,
2015; Quistgaard et al, 2016).
Using only fitness functions and in vivo protein levels from
strains expressing tet(B) and tet(B) variants, we were able to
construct a simple but robust model capable of predicting physico-
chemical properties describing substrate binding rate and pumping
efficiency of TetB and variants. For these variants, our data are in
good agreement with the current knowledge of how MFS transporter
structure determines function. Our success in determining quantita-
tive physicochemical properties from fitness at varying selective
conditions suggests that with the appropriate mathematical model,
libraries of protein variants can be rapidly screened without the
need for individual protein purification or that small molecule
libraries of potential inhibitors of those MFS family members associ-
ated with antibiotic resistance could be screened rapidly and useful
biochemical properties ascribed without prior in vitro
characterization.
Results
Baseline response of a cellular system without tet(B) is used to
determine global parameters
While the qualitative concept of cellular phenotype as a product of
protein(s) function is clear, the ability to deconstruct and accurately
map the phenotype to physicochemical properties of a specific
protein within the larger cellular milieu is an interesting challenge
(Tan et al, 2012; Walkiewicz et al, 2012). We describe a general
mathematical model that allows us to relate changes in fitness func-
tion to changes in biophysical behaviors and could be applied to
any effluxer that contributes strongly to fitness over a set of envi-
ronmental conditions. To establish the global parameters required
for the overall system, we measured the growth rate of the host
cell, E. coli BW25113 without the effluxer tet(B) under a range of
environmental selection conditions which for TetB are the antibi-
otics TET, DOX, and MCN. These fitness functions comprise the
baseline response of the cellular system, which include any poten-
tial effects from other pumps or resistance mechanisms, and allow
us to isolate the effects of tet(B) on fitness when it is added to the
system. Without expression of tet(B), we assume that diffusion is
the major factor influencing the steady-state concentration of antibi-
otic in the cytoplasm. Previous work has shown that for TET the
concentration of drug in the cytoplasm, [S]C, is about four times
that in the media, [S]M, (Thanassi et al, 1995). Both DOX and MCN
are more lipophilic than TET, which may lead to differences in their
diffusion patterns; however, for the model presented here we take
this same diffusion relationship for DOX and MCN (Fig 1A). The fit-
ness function curves were fit to the following Hill-function relation
that describes growth rate inhibition by cytoplasmic drug
concentration
GR ¼ 1 S½ 
B
C
AB þ ½SBC
; (1)
where [S]C is the concentration of substrate in the cytoplasm and
A and B are global parameters that describe our specific cellular
system (Fig 1, Table 1 and Code EV2). The tetracycline antibiotics
inhibit growth by binding to the 30S ribosomal subunit. This inter-
action is represented through A, which corresponds to the cyto-
plasmic drug concentration, [S]C, at which the normalized growth
rate is half maximal. Additionally, global parameter A can roughly
be interpreted as the apparent Kd of the antibiotic binding to the
ribosome although it does not take into account other cellular sinks
of the antibiotic (Walkiewicz et al, 2012). Global parameter B is
the Hill coefficient that describes the shape of the dose–response
curve in response to antibiotic. It should be noted that our host
strain E. coli BW25113, in contrast to many E. coli strains, has a
higher intrinsic resistance to DOX and MCN than TET (Fig 1B).
This intrinsic resistance, however, is captured by our model and
reflected in parameter A where this value is largest for MCN and
smallest of TET (Table 1).
A physiological model describing TetB efflux pump kinetics can
be used to determine physicochemical parameters from fitness
Determining physicochemical properties from fitness at selective
conditions requires the use of an appropriate physiological model.
To do this, we mathematically modeled how a MFS efflux pump
counteracts substrate diffusion in vivo. As an antiporter, TetB
reduces the concentration of antibiotic in the cytoplasm by utilizing
the proton motive force to pump one proton into the cytoplasm and
pump out one tetracycline-Mg1+ complex into the periplasm. Analy-
sis of the BW25113 pump-free system allowed us to directly predict
the concentration of antibiotic in the cytoplasm by the measured
growth rate (equation 1). We can determine the substrate binding
rate and pumping efficiency necessary to achieve the predicted
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concentrations of antibiotic in the cytoplasm, by first modeling drug
binding and unbinding to pump, and ultimately efflux into the peri-
plasm (Fig 2A).
SC þ PA¢
k1
k1
PO; (2)
PO!
r
SP þ PA: (3)
Equation (2) represents a substrate in the cytoplasm (SC) binding
to an available pump (PA) at a rate, k1, to become an occupied pump
(PO). The substrate in the cytoplasm can also dissociate from the
pump at rate, k1. Once the substrate is bound to the pump, it can be
transported to the periplasm (SP) at pump efficiency rate, r, thereby
returning the pump to the available state (equation 3). We can
model these dynamics by taking a generalized mass action model
coupled with diffusion to arrive at the following dynamic model:
d S½ P
dt
¼ D1 S½ M  0:5 S½ P
  D2 S½ P  0:5 S½ C þ rPO; (4)
d S½ C
dt
¼ D2 S½ P  0:5 S½ C
 þ  S½ CPAk1 þ k1PO; (5)
dPA
dt
¼  S½ CPAk1 þ POk1 þ rPO; (6)
dPO
dt
¼ S½ CPAk1  POk1  rPO: (7)
In equations (4) and (5), D1 and D2 are the diffusion constants
across the outer membrane and inner membrane, respectively. The
input into the model is the antibiotic concentration in the media
([S]M). This is the antibiotic concentration used in the growth rate
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Figure 1. Model incorporating substrate diffusion can be used to determine global parameters that describe the baseline response of the cellular system at a
range of environmental selection conditions.
A Diffusion model including inhibition of growth rate by tetracycline antibiotics. The diffusion pattern presented is specific for TET in Escherichia coli. DOX and MCN are
second-generation tetracycline antibiotics, which were created to have greater potency. For this model, however, we assume that the TET diffusion model is
comparable to DOX and MCN.
B Normalized fitness functions of E. coli BW25113 in the absence of tet(B) and their corresponding model fits in the presence of varying concentrations of antibiotics
TET, DOX, and MCN in the media ([S]M). Normalized quadruplicate data are shown for each antibiotic.
Source data are available online for this figure.
Table 1. Global parameters A and B, which describe the baseline
response of the cellular system, were computed from fitness functions
of Escherichia coli BW25113 in TET, DOX, and MCN using equation (1).
Max Min Average LS fit SD
TET
A 2.68 1.9 2.29 2.16 0.39
B 1.02 1.37 1.20 1.15 0.18
DOX
A 4.84 4.18 4.51 4.55 0.33
B 1.32 1.46 1.39 1.34 0.07
MCN
A 6.67 6.25 6.46 6.44 0.21
B 2.03 2.36 2.20 2.18 0.17
The values presented in this table were generated by a least squares (LS)
fit of the average experimental fitness functions plotted in Fig 1.
Parameter A has units of lg/ml and corresponds to the cytoplasmic drug
concentration, [S]C, at which the normalized growth rate is half maximal.
Parameter A can also roughly be interpreted as the apparent Kd of the
drug to the ribosome in addition to all other intercellular drug
interactions. Parameter B is the Hill coefficient that describes the shape of
the dose–response curve in response to the antibiotic and is thus a highly
complex lumped parameter that models essentially all aspects of cellular
physiology as one variable.
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assays. The ordinary differential equations then model changes in
the antibiotic concentration in the periplasm ([S]P) and cytoplasm
([S]C) based on [S]M as well as pump kinetics. In the absence of tet
(B) expression, we assume steady-state concentrations of tetracy-
cline antibiotics are due solely to diffusion and the Gibbs–Donnan
effect. Tetracycline is concentrated 2× from the media to the peri-
plasm and again 2× from the periplasm into the cytoplasm resulting
in a total 4× concentration in the cytoplasm, [S]C, compared to the
media, [S]M (Thanassi et al, 1995).
We then solve for the steady state of the system above. From
equation (6)
rPO þ POk1 ¼ S½ CPAk1: (8)
We substitute PO = Ptot  PA and solve for PA
PA ¼ jðPtotÞjþ S½ C
; (9)
where
j ¼ r þ k1ð Þ
k1
: (10)
Furthermore, from equation (4) we have
D1 S½ M  0:5 S½ P
  D2 S½ P  0:5 S½ C  ¼ rPO; (11)
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Figure 2. Model incorporating efflux kinetics predicts lumped physicochemical pump parameters from growth rates.
A TetB model description including the effect of TetB to reduce cytoplasmic concentrations of drug to relieve the inhibition of translation. PA and PO describe an
available and occupied pump, respectively. Drug can bind PA by a rate, k1, to create PO where two events can occur: (i) Drug disassociates from the pump at a rate,
k1, or (ii) Drug is transported into the periplasm at a pump efficiency rate, r.
B Normalized fitness functions of cells expressing wild-type tet(B) and their corresponding model fits in the presence of TET, DOX, and MCN. Triplicate data are shown
for each antibiotic.
C Predicted concentrations of TET in the cytoplasm as a function of TET concentration in the media, j, and c. The j and c values held constant in the plots are those for
wild-type TetB.
Source data are available online for this figure.
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D1 S½ M  0:5 S½ P
  D2 S½ P  0:5 S½ C  ¼ rPtot þ rPA; (12)
D1 S½ M  0:5 S½ P
  D2 S½ P  0:5 S½ C  ¼ r Ptot S½ Cjþ S½ C : (13)
From equation (5), we have
D2 S½ P  0:5 S½ C
 þ k1PO ¼ ½SC PAk1; (14)
D2 S½ P  0:5 S½ C
 þ k1 Ptot S½ Cjþ S½ C ¼ S½ C
j Ptotð Þ
jþ S½ C
k1; (15)
and rearranging terms, we get
D2 S½ P  0:5 S½ C
  ¼ Ptot S½ C
jþ S½ C
ðjk1  k1Þ; (16)
D2 S½ P  0:5 S½ C
  ¼ r Ptot S½ C
jþ S½ C
: (17)
Plugging in equation (17) into equation (13) gives
S½ M ¼ 0:5 S½ P; (18)
relating the concentration of substrate in the periplasm ([S]P) to
the concentration in the media ([S]M). We can solve for the
concentration of substrate in the cytoplasm ([S]C) as a function of
concentration of substrate in the media by substituting equa-
tion (18) into equation (17)
4 S½ M  S½ C ¼ c
S½ C
jþ S½ C
; (19)
where
c ¼ 2rPtot
D2
: (20)
Finally, solving for [S]C as a function of [S]M gives
S½ C ¼
 cþ j 4 S½ M
  ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffifficþ j 4 S½ M 2 þ 16j S½ M
q
2
; (21)
for which the positive solution is the only feasible solution. We
assume that substrate diffusion across the inner membrane, D2,
remains constant. In order to fit parameters using growth rate data,
we combine equation (21) with equation (1), which relates growth
rate to the concentration of substrate in the cytoplasm,
GR ¼ 1 S½ BC
ABþ½SBC
: Efflux pumps counteract substrate diffusion, and
therefore, we cannot know the concentration of substrate in the
cytoplasm, [S]C, by simply knowing the substrate concentration in
the media, [S]M. Using equation (1) and the global parameters A
and B determined in the pump-free system allow us to calculate
[S]C from fitness (growth rates) of strains with the transporter.
Equation (21) is then used for the prediction of the pump parame-
ters, c, relating to the total activity of the transporter and j, which
roughly corresponds to the affinity of substrate to the transporter,
and Ptot is the total amount of protein.
This model was used to fit fitness data of strains expressing a
chromosomal copy of tet(B) at a wide range of TET, DOX, and
MCN concentrations (Fig 2). In vivo, the expression of most efflux
pumps is tightly regulated by repressors as their expression in
non-selective environments can lead to substantial fitness costs
(Nguyen et al, 1989). In naturally occurring biological systems,
Tet(B) is controlled by the TetR repressor whereby expression is
dynamically controlled by the concentration of tetracycline in the
environment (Møller et al, 2016). In an effort to more easily
predict pump physicochemical properties from fitness in selective
environments, we removed these regulatory dynamics by TetR.
Here, tet(B) is expressed by the arabinose-inducible, glucose-
repressible promoter, pBAD, where we use a saturating arabinose
concentration to obtain a largely homogeneous cellular population
expressing tet(B) (Khlebnikov et al, 2000). We ensured moderate
translational expression of TetB by engineering a ribosome bind-
ing site (RBS) sequence that provided measurable resistance at
minimal fitness cost (Materials and Methods; Salis et al, 2009).
The final construct was integrated into the E. coli BW25113 chro-
mosome using a site-specific method for insertion at the Tn7
attachment sites downstream of the highly conserved glutamine
synthetase gene, glmS (McKenzie & Craig, 2006). Our host strain
BW25113 has a deletion in the genes necessary for arabinose
catabolism; therefore, tet(B) expression is under constant induc-
tion in the presence of saturating arabinose, and we assume that
Ptot is constant within our system (Grenier et al, 2014). Previous
work has shown that inadvertent coupling between growth rate
and gene expression can lead to bistability in growth response of
a drug-resistant E. coli strain in the presence of chloramphenicol
(Deris et al, 2013). The authors show this using a phenomenolog-
ical model, where concentrations of the drug-deactivating enzyme
chloramphenicol acetyltransferase are growth rate dependent.
Here, we greatly minimize any measurable coupling between
expression of TetB and growth rate of the cell through the
constant saturating induction of the inducible promoter. This
allows us to create a simpler physiological model that can
provide more information about the kinetic properties of the
protein.
Using our physicochemical-fitness model, we generated least
squares fits to normalized fitness functions for cells expressing tet
(B) under selection by TET, DOX, or MCN and determined parame-
ters j and c (Fig 2B, Appendix Table S1 and Code EV2). In our
system, we assume that Ptot and drug diffusion across the inner
membrane (D2) remain constant. Here, TetB more readily pumps
out TET compared to DOX and MCN, which is consistent with previ-
ous studies performed with tet(B) (Testa et al, 1993; Nguyen et al,
2014). Figure 2C shows how the final steady-state concentration of
TET in the cytoplasm relates to a given concentration in the media
based on equation (8). We find that there is a strong correlation
between c and changes in growth rate. This is expected since c,
equation (20), is proportional to protein concentration and pumping
efficiency, which greatly impacts the cytoplasmic concentration of
antibiotic. Similar to our previous report, we find that j, relating to
substrate affinity defined in equation (10), is sensitive to the initial
plateau of the fitness function at lower concentrations of antibiotic
while c, relating to total activity, is sensitive to the changes in the
ª 2017 The Authors Molecular Systems Biology 13: 964 | 2017
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growth rate as substrate concentration increases (Appendix Fig S1;
Walkiewicz et al, 2012).
Fitness functions of tet(B) variants can be modeled accurately to
reveal relevant physicochemical properties of efflux pumps
To test the ability of our physicochemical-fitness model to determine
physicochemical parameters relating to substrate affinity and total
protein activity from fitness, we tested known TetB variants that have
been shown to reduce TetB function (Sapunaric & Levy, 2005). Vari-
ants were also selected for their predicted location in the conserved
MFS fold for TetB and their potential to alter pumping efficiency and
substrate binding affinity. The majority of MFS transporters have an
N- and C-terminal domain, each consisting of six transmembrane
helices and joined by the cytoplasmic interdomain loop (Fig 3A).
There are three groups of four alpha helices that interact to form the
canonical MFS fold. Here, we use the nomenclature from Quistgaard
et al, 2016 for the helices. A-helices shown in blue (TM1, TM4, TM7,
and TM10) are positioned at the center of the transporter and make
up the transport path needed for substrate binding and exchange or
cotransport coupling. B-helices shown in green (TM2, TM5, TM8, and
TM11) are positioned outside of the core helices and have been shown
to help mediate the N- and C-domain interface and may also partici-
pate in substrate binding. C-helices shown in gray (TM3, TM6, TM9,
and TM12) are positioned on the outside of the core helices and have
been postulated to primarily contribute more to the structure than the
function of the transporter (Yan, 2013).
In addition, we tested four variants within the interdomain loop
of TetB at residues D190 and E192 that have been suggested to be
important for substrate specificity and reduce tetracycline sensitivity
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Figure 3. Physicochemical properties of TetB variants can be determined from cellular fitness.
A Variant locations on the predicted TetB topology. A-helices are shown in blue, B-helices are shown in green, and C-helices are shown in gray.
B Model fits for Escherichia coli BW25113 strains expressing a chromosomal copy of tet(B)WT and seven variants in TET, DOX, and MCN. Our model fit triplicate fitness
function data for all strains (Appendix Fig S2). At low drug concentrations for all antibiotics, tet(B)G366C exhibits much slower growth rates than wild type. Compared
to wild type, strains expressing tet(B)L9F exhibit similar growth rates at low and high drug concentrations but have faster growth rates at intermediate drug
concentrations.
C Fitness landscapes with mutants overlaid for TET = 35 lg/ml, DOX = 10 lg/ml, and MCN = 2.5 lg/ml corresponding to the dashed lines in panel (B).
Source data are available online for this figure.
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(Tamura et al, 2001; Sapunaric & Levy, 2005). Studies with other
MFS transporters, however, indicate that the interdomain loop is
necessary for movement and flexibility between the N- and C-term-
inal domains to facilitate the pumping mechanism required for
substrate translocation (Law et al, 2008; Dang et al, 2010).
In total, seven different tet(B) variant constructs were created
using site-directed mutagenesis and integrated into the chromosome
of the parent strain for subsequent growth rate analysis in TET,
DOX, and MCN (Fig 3A and B, and Appendix Fig S2). Insertion and
expression of tet(B) or variants resulted in modest fitness costs
within our cellular system (Appendix Fig S3). For all tested variants,
an increase in drug concentration caused a decrease in growth rate.
Surprisingly, interdomain loop variants tet(B)D190N, tet(B)E192D, and
tet(B)E192Q identified by Sapunaric and Levy (2005) as reducing TetB
function showed fitness nearly identical to cells expressing tet(B)WT
and as expected, our model correctly predicted similar j and c
parameters as can be seen by their overlap in the fitness landscape
in Fig 3C. Cells expressing tet(B)V339C, located in B-helix TM11, had
a greater decrease in fitness compared to cells expressing tet(B)WT
in TET and MCN. In DOX, both fitness functions overlapped show-
ing that a decrease in fitness is not observed during DOX selection.
In Fig 3C, parameters for TetBV339C can be differentiated from
TetBWT in TET and MCN but is clustered with TetBWT in DOX. The
strain expressing tet(B)L9F located in A-helix TM1, surprisingly, is
noticeably more fit than cells expressing tet(B)WT in all tested drugs
although in the work of Sapunaric and Levy this variant was shown
to produce a decrease in resistance. Interestingly, c remained similar
to WT, while j changed 2.5-fold in all drugs (Appendix Table S1).
This result echoes our previous work showing that small changes in
protein function can result in large fitness effects (Walkiewicz et al,
2012). Cells expressing tet(B)G366C, located in C-helix TM12, were
significantly less fit than cells expressing tet(B)WT. This mutation
resulted in severe decreases in both j and c in all drugs.
Small changes in in vivo protein levels play a decidedly important
role in determining fitness
The total activity of a transporter is a result of both its pump efficiency
and concentration. In the absence of knowing protein concentration, it
is impossible to obtain information regarding changes in pumping effi-
ciency from the lumped parameter, c, determined solely from growth
rates (equation 9). Although we used a collection of single amino acid
substitutions, it is likely that some of these mutations may have
affected the steady-state concentration of TetB, and thus, it would be
inaccurate to ascribe changes in c solely to changes in pumping rate.
We therefore performed Western blot analysis to assess the potential
importance for small changes in protein concentration to drive
increased fitness. We used an antibody toward TetB to quantify rela-
tive total protein concentration using the membrane fraction of strains
expressing chromosomal copies of tet(B)WT and variants harvested at
mid-exponential growth phase (Appendix Figs S5 and S6). As shown
in Fig 4, the in vivo protein level of TetBL9F is ~50% higher than wild
type, while TetBV339C and TetBG366C appear somewhat lower by ~20
and ~50%, respectively. The in vivo expression of all interdomain loop
variants was similar to wild type and, when combined with their fit-
ness data in Fig 3B, indicates that these variants do not alter TetB
physicochemical properties in our system. Subsequent analyses of
these variants are discussed in the Appendix Figs S7 and S8. These
data highlight the importance of incorporating in vivo protein levels in
the physicochemical-fitness model as this factor played an important
Figure 4. In vivo protein levels of TetB variants relative to wild type determined by Western blot analysis of triplicate cell membrane fractions using an
antibody for the C-terminal tail of TetB.
Escherichia coli BW25113 strains expressing a chromosomal copy of tet(B)WT or variant were grown in 2% arabinose-supplemented LB in the absence of drug and harvested at
mid-exponential phase. Membrane samples were prepared from three individual colonies grown independently (Appendix Figs S5 and S6). Compared to wild type, strains
expressing tet(B)L9F consistently have higher in vivo protein levels whereas strains expressing tet(B)V339C and tet(B)G366C have lower in vivo protein levels as detected by
Western blot analysis. All four variants located in the interdomain loop exhibited in vivo protein levels similar to wild type.
Source data are available online for this figure.
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role in the increased fitness of cells expressing tet(B)L9F and decreased
fitness of cells expressing tet(B)G366C.
The relative change in substrate binding and pumping efficiency
rates can be determined after incorporation of protein
concentration into the physicochemical-fitness model
Integrating in vivo protein levels into our physicochemical-fitness
model allows for the uncoupling of lumped parameters c and j into
the specific properties describing substrate binding rate, k1, and
pumping efficiency rate, r. Although it is not possible to find explicit
values for the rate constants, we can determine the effective relative
changes in k1 and r for each variant across TET, DOX, and MCN.
Relative changes in r were determined by incorporating protein
levels directly into our definition of c in equation (9). We deter-
mined relative changes in k1 through the ratio c/j. Consider
c
j
¼ rk1
r þ k1ð Þ :
Ptot
D2
: (22)
If we divide through by k1, we get
c
j
¼ r
r=k1 þ eð Þ :
Ptot
D2
; (23)
where e = k1/k1. We assume that the off binding rate of substrate
to TetB is much lower than the on binding rate (i.e., e = k1/
k1  1). Expanding equation (23) around e in a Taylor series to
second order, we get
c
j
 k1  k
2
1
r
eþ k
3
1
r2
e2 þ . . .
 
:
Ptot
D2
: (24)
Substituting back in the definition for e, we find that if
k1  r, then a zero-order approximation holds and we
should expect that j ¼ r þ k1ð Þ=k1 correlates linearly with
c ¼ 2rPtot=D2. In this case, the relationship is described by the zero-
order approximation
c
j
 k1 2Ptot
D2
: (25)
This assumption was tested for each tet(B) variant. We took a
Monte Carlo approach to generate 1,000 samples of fits on j and c
through a random selection of global parameters A and B from the
estimated probability density functions (details in Materials and
Methods). Figure 5A shows the fits for strains expressing tet(B)WT
and variants tet(B)L9F, tet(B)V339C, and tet(B)G366C where, indeed,
there appears to be a linear correlation between j and c. The calcu-
lated ratio c/j for these strains are shown in Fig 5B where error bars
correspond to error from A and B parameter estimations. The major-
ity of the cases have relatively modest error indicating a consistent
measurement of ratio c/j even in the presence of uncertainty in A
and B. The large error within ratio c/j for both TetBV339C and
0 5 10
0
200
400
600
800
1000
1200
TET
0
200
400
600
800
0 10 20
0
50
100
150
200
250
DOX
0
20
40
60
80
100
0 1000 2000
0
200
400
600
800
MCN
0
5
10
15
20
L9F V339C G366CWT
113± 3.4x103
52999 ± 7.2x103
B
A
L9F V339C G366CWT L9F V339C G366CWT
Figure 5. Statistics of ratio c/j allow us to test first-order approximation assumptions.
A The spread of j and c fits for 1,000 randomly selected parameters A and B from a set gamma distribution shows a linear correlation between j and c.
B The calculated mean and error of c/j for the sampled parameter fittings shown in Appendix Fig S2. The large error seen for TetBV339C and TetBG366C in MCN reveals
that we cannot make the first-order approximation within cj  k1 2PtotD2 .
Molecular Systems Biology 13: 964 | 2017 ª 2017 The Authors
Molecular Systems Biology In vivo efflux pump characterization Anisha M Perez et al
8
TetBG366C in MCN informs us that we cannot make any conclusions
about fold changes in the parameter k1 with confidence. This large
error is due to the large uncertainty in the j prediction for these
two variants, which amplifies significantly in the ratio c/j
(Appendix Table S2). We hypothesize that the large error in j is due
to the nearly negligible fitness increase produced by strains express-
ing tet(B)V339C and tet(B)G366C compared to the strain without a tet
(B) allele showing an insensitivity of our model to confidently
predict j (Appendix Fig S9) at very low levels of protein activity. In
all further analysis, we omitted any fold change calculations in k1
for TetBV339C and TetBG366C in MCN; however, we do obtain a confi-
dent prediction of c for TetBV339C, which relates closely to the drop-
off point of the fitness function rather than the subtle difference in
the slope.
Next, we calculate relative changes in parameters k1 and r
incorporating uncertainty in A and B as well as protein concen-
tration measurements. Although we were able to determine rela-
tive protein levels within 30%, the challenge in precisely
estimating in vivo protein levels for membrane proteins is a large
cause of uncertainty in our calculations. Therefore, the error
propagated here is hindered by the resolution of the Ptot estima-
tion (Fig 4). Additionally, the uncertainty in our least squares fit
of j and c is from error propagated from the estimation of A and
B. In order to calculate the terms involving j and c for the mean
and variance calculations of the relative changes in k1 and r, we
used the data generated from the Monte Carlo approach in
Table 1.
Incorporating relative in vivo protein levels and uncertainty in A
and B, we used equation (25) to determine relative change in
substrate binding rate, k1, and c defined in equation (20) to deter-
mine the relative change in pumping efficiency, r. The relative
change in the parameter r is calculated as
Dr ¼ rm  rwt
rwt
¼ cm
cwt
Ptot;wt
Ptot;m
 1
: (26)
This is found by solving for r in equation (20), which defines
c ¼ 2rPtot=D2. We apply the expectation operator and get that the
mean of Dr is
E Dr½  ¼ E cm
cwt
 
E
Ptot;wt
Ptot;m
 
 1; (27)
and the corresponding variance is
Var Drð Þ ¼ E Dr2	 
 E Dr½ ð Þ2
¼ E cm
cwt
 2" #
E
Ptot;wt
Ptot;m
 2" #
 E cm
cwt
 
E
Ptot;wt
Ptot;m
  2 :
(28)
Similarly, with the expression c/j  k1 Ptot/D2 and equa-
tion (10), we have
Dk1 ¼ cm  jwtcwt  jm
Ptot;wt
Ptot;m
 1 (29)
with mean
E Dk1½  ¼ E cm  jwtcwt  jm
 
E
Ptot;wt
Ptot;m
 
 1 (30)
and variance
Var Dk1ð Þ ¼ E Dk21
	 
 E Dk1½ ð Þ2
¼ E cm  jwt
cwt  jm
 2" #
E
Ptot;wt
Ptot;m
 2" #
 E cm  jwt
cwt  jm
 
E
Ptot;wt
Ptot;m
  2 :
(31)
Figure 6A shows the relative changes in k1 and r across the
variants compared to TetBWT. TetBG366C significantly reduces the
relative pumping efficiency but minimally impacts the binding rate
constant in TET and DOX. TetBL9F produces both an increase in
relative binding affinity and decreases in pumping efficiency across
all drugs by comparable magnitudes. We know from Fig 2C that
the lumped parameter c is primarily implicated in altering the cyto-
plasmic drug concentration. For cells expressing tet(B)L9F, their
decrease in pumping efficiency is compensated for by the increase
in protein levels. The effect of mutant TetBV339C, interestingly, is
quite variable across the three different drugs even when
Appendix Fig S4 shows a consistent change in drug specificity
across all mutants. Although the relative pumping efficiency is
slightly larger by ~25%, the in vivo protein level of TetBV339C is
slightly lower than WT resulting in overlapping fitness functions
in DOX.
The physicochemical-fitness model can be used to screen a large
plasmid-encoded protein library
Having established that chromosomally encoded variants of TetB
could be well modeled by our approach, we went on to test the effi-
cacy of our method to a plasmid-encoded library of TetB variants.
Plasmid-encoded libraries of protein variants are frequently used for
high-throughput screening and, therefore, it was important to estab-
lish the utility of the approach to a format used more broadly during
drug development. The lumped parameters j and c are determined
solely from growth rates and provide a way for libraries to be
screened for a desired trait, such as altered substrate affinity and/or
total activity. To demonstrate the library screening potential of our
model, we created an error-prone PCR mutant tet(B) library
harbored on a low-copy-number plasmid and performed growth
analysis on a small subset of variants. In addition, new A and B
global parameters describing the baseline response of this system to
TET were determined using a strain containing an empty plasmid.
These values were calculated to be A = 1.91 and B = 1.42 and are
comparable to the first analysis performed in the absence of empty
plasmid (Table 1 and Dataset EV2). Functional TetB variants were
isolated and initially screened via replica plating and growth analy-
sis at a single TET concentration (details in Materials and Methods).
We analyzed seven TetB variants selected from an initial functional
screen and performed growth analysis in TET. Of the seven variants,
five were able to grow in the TET concentrations tested in the
growth assay. Two variants exhibited fitness functions similar to
WT, one exhibited highly variable fitness functions, and two
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variants, variant 6 and variant 7, were less fit than WT (Fig 7A,
Appendix Fig S10 and Table S3, Appendix Source Data).
Variant 6 contained three SNPs; K183E is located within the
interdomain loop, A290V is located in C-helix TM 9, and T326I is
located within the short cytoplasmic loop connecting TM 10 and TM
11 (Fig 7C). The mutations within this variant produce a 187%
increase in j and 86% increase in c relative to WT (Fig 7B). The
increase in c represents an increase in total protein activity of vari-
ant 6; however, there is an even greater increase in j representing
decreased binding affinity to TET resulting in an overall decrease in
fitness compared to WT (Fig 7A and B). Variant 7 also has three
SNPs: F151I located in B-helix TM 5, F179L located within the inter-
domain loop, and T326A, interestingly, at the same locus as variant
6 mutation T326I. In the strain expressing plasmid variant 7, we
observe a 30% decrease in the c parameter while the j remains
unchanged compared to WT TetB in plasmid (Fig 7B).
Discussion
Determination of the physicochemical properties of a single specific
protein solely from fitness poses an interesting but difficult challenge
TET DOX MCN TET DOX MCN TET DOX MCN
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B
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Figure 6. Relative changes in k1 and r can be uncoupled from j and c using in vivo protein levels.
A Changes in drug binding affinity Dk1 and pumping efficiency Dr for TetB variants relative to wild type in TET, DOX, and MCN. Error bars are comprised from a
propagation of errors from A and B global parameter modeling and in vivo protein-level determination.
B Homology model of TetB using YajR (PDB 3wdo) built using Phyre2 where the periplasmic side is on top and the cytoplasmic side is on the bottom. The A-helices are
shown in blue, B-helices are shown in green, C-helices are shown in gray, and the interdomain loop is in cyan. Spheres indicating variant positions were made using
PyMOL (L9, pink; V339, purple; G366, orange). Right image depicts the view through the central TetB pore from the periplasm into the cytoplasm.
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as the phenotype of an organism is the summation of the physico-
chemical properties of all cellular proteins and their interactions
(Deris et al, 2013). Here, we take an otherwise complex phenotype,
resistance to tetracycline mediated by TetB, and examined the fitness
of E. coli at varying environmental conditions to link in vivo TetB
function to its physicochemical properties. Wild-type tet(B) and
strategically chosen variants were used to test the hypothesis that we
could extract meaningful information regarding substrate binding
and pumping efficiency solely from growth at selective conditions
and relative in vivo protein concentrations. We built a simple but
robust mathematical model that incorporates substrate diffusion,
cytoplasmic substrate concentration, and growth at selective condi-
tions to predict relative changes in these pump parameters and could
be extended as a general framework for other MFS family members.
We further expanded upon this framework to show that our model
can be used to screen and assay protein libraries solely from growth
at selective conditions to help identify variants of a desired trait.
We first determined the global parameters A and B that define
our cellular system from growth analysis of our host cell without tet
(B) in the chromosome using a Hill-function relating growth rate
inhibition and cytoplasmic drug concentration. Interestingly, our
host cell has an intrinsically higher resistance to semisynthetic,
second-generation tetracycline antibiotics DOX and MCN compared
to TET. This unexpected feature emphasizes the importance of
obtaining A and B for all tested substrates as the determination of
the relative pump parameters is dependent on these initial global
parameters.
From our steady-state model, we find that the cellular fitness
response emerges from a balance between diffusion and transport,
which takes on dynamics analogous to Michaelis–Menten kinetics
typically used to describe transporters (Law et al, 2007; Sun et al,
2012). Our model was able to extrapolate information from the fit-
ness function curves and estimate two lumped parameters, j and c.
j is the ratio between the reaction rates resulting in unbound and
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Figure 7. The physicochemical-fitness model can be used to screen plasmid-encoded libraries of protein variants.
A Triplicate normalized fitness functions (*) for Escherichia coli BW25113 strains harboring plasmid copies of tet(B)WT, tet(B)K183E,A290V,T326I (variant 6) and
tet(B)F151I,F179L,T326A (variant 7) in TET and their corresponding least squares model fits (solid line) where both variants display decreased fitness in TET compared to WT.
B Percent change relative to WT in parameters j and c for strains expressing tet(B)K183E,A290V,T326I and tet(B)F151I,F179L,T326A. Parameter values were determined by the
least squares model fits in (A).
C Homology model of TetB using YajR (PDB 3wdo) built using Phyre2 where the periplasmic side is on top and the cytoplasmic side is on the bottom. The A-helices are
shown in blue, B-helices are shown in green, C-helices are shown in gray, and the interdomain loop is cyan. Spheres indicating variant positions were made using
PyMOL (K183 and A290, red; F151 and F179, orange; T326, black, as this residue is altered in variants 6 and 7). The right image depicts the view through central TetB
pore from the periplasm into the cytoplasm.
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bound states of the pump while c is proportional to the pump effi-
ciency and protein concentration. These parameters are loosely
analogous to Km and Vmax in Michaelis–Menten kinetics, respec-
tively. Our model cannot distinguish between changes in pumping
efficiency or protein levels as both equally impact c, the apparent
Vmax. However, by incorporating relative in vivo protein concentra-
tion, we were able to use the model to extrapolate more detailed
information regarding specific protein activities. It is important to
note that the model does not require measurement of protein
concentration in vivo but only aids in discerning between changes
in catalytic activity (kcat) versus total protein concentration (Ptot).
Although absolute values of j and c were shown to be sensitive
to predicted values of A and B, we note that as a first screening
process; Fig 5A still demonstrates a visible distinction for variants
whose fitness differs from wild type. These parameters can serve as
a good initial screening method when looking for variants with
specific qualities. Furthermore, comparing Figs 5A with 6A high-
lights the sensitivity of the model. A main source of error in this
analysis arises from the estimation of protein levels relative to WT.
This additional analysis, however, allowed for better understanding
of the specific physicochemical property impacted by these variants
as it relates to the overall performance of TetB.
Of the seven chromosomally encoded variants tested in this
study, three conferred significant changes in fitness allowing for
their relative changes in substrate binding rate, k1, and pumping
efficiency, r, to be determined. TetBL9F is located in the A-helices
postulated to make up the transport path and be involved in
substrate binding (Fig 6B). Modeling growth rate information and
incorporating protein levels revealed that, indeed, this mutation
impacted binding rate; however, pumping efficiency was also
impacted to a comparable level in all drugs. Despite the decreased
pumping efficiency, the increase in fitness experienced by the strain
expressing tet(B)L9F is due to a combination of both greater protein
levels and an increase in k1 relative to cells expressing tet(B)
WT.
TetBG366C is located in the C-helices that are proposed to be involved
in maintaining the structural integrity of MFS transporter (Yan,
2013). The strain expressing tet(B)G366C had a severe decrease in fit-
ness compared to wild type in all drugs. Incorporation of in vivo
protein levels into modeling revealed that, indeed, this mutation
impacts pumping efficiency to a greater extent than substrate bind-
ing consistent with our current knowledge of the C-helices (Fig 6A
and B). The decrease in fitness of cells expressing this variant is due
to a combination of lower in vivo protein levels and pumping effi-
ciency relative to the tet(B)WT strain. Cells expressing B-helix
mutant tet(B)V339C showed minimal but statistically significant
increases in k1 in DOX and no change in TET and could not be
resolved for MCN. Interestingly, the strain expressing tet(B)V339C
manifested changes in pumping efficiency, r, for each drug, but the
extent of change was dissimilar for all drugs, suggesting that while
there was no change in specificity, there were generalized changes
in how well this variant could pump across the membrane
(Appendix Fig S4). Since the B-helices are postulated to mediate the
N- and C-domain interface, it is possible that the mutation V339C is
impacting this interface in such a way in TetB that substrate trans-
port is differentially altered in TET, DOX, and MCN.
We tested four variants located in the interdomain loop:
TetBD190N, TetBE192A, TetBE192D, and TetBE192Q. These variants did
not significantly alter cellular fitness in our study, differing from a
previous study, which suggested that these loop residues contribute
to substrate specificity (Sapunaric & Levy, 2005). One reason for this
difference may lie in the differing cellular context for which the
studies were performed. Previous reports have shown that tetB
expression is dynamically regulated by the TetR repressor, in direct
response to tetracycline concentration while in our system, TetR is
absent and the in vivo TetB concentration is kept constant (Møller
et al, 2016).
We also show that our system can be used to screen and assay
protein libraries by creating and testing a tet(B) plasmid mutant
library in TET. We quickly created, screened, and determined the
lumped parameter j and c values for tet(B) library variants using
only whole cells and without the challenging task of protein purifi-
cation. The modeling of the strain harboring plasmid variant six
triple mutant tet(B)K183E,A290V,T326I exhibited weaker substrate bind-
ing for TET as indicated by a 187% increase in j, the apparent Km,
but an increase in total protein activity indicated by a 86% increase
in the c parameter. We know from Fig 2C that c has a larger influ-
ence on the concentration of TET in the cytoplasm than j and,
therefore, more heavily influences cellular fitness; however, the
magnitude of the decrease in j is ~2 fold more than the increase in c
resulting in a modest fitness decrease compared to WT. Plasmid
variant 7 triple mutant tet(B)F151I,F179L,T326A solely exhibited a 30%
decrease in total protein activity. Two of the three mutations within
variant 7 alter bulky aromatic phenylalanine residue to smaller
aliphatic isoleucine and leucine residues, which may impact the
overall ability of TetB to pump out TET. Interestingly, both variants
6 and 7 harbor mutations, which alter polar residue T326 to
aliphatic residues. Without analyzing the specific single mutations
of these triple mutants, we can only determine how the combined
effects of these mutations impact protein parameters.
Although our characterization method is able to provide mean-
ingful information about the mutated residue and location, our
simplified model does not incorporate all possible kinetic events
needed for substrate efflux or drug:cellular interactions. For exam-
ple, our model does not incorporate the details about co-substrate
transport for H+ in our TetB system or how cytoplasmic drug
binding to the ribosome may impact the concentration of [S]C
available for TetB efflux. Additionally, we have omitted the bind-
ing of cytoplasmic drug [S]C to a ribosome. This competition for
binding effectively acts to reduce the concentration of [S]C avail-
able to bind to the pump and is dependent on the growth rate
(Klumpp & Hwa, 2014; Scott et al, 2014; Hui et al, 2015). Although
this would affect any absolute estimates of binding rates (resulting
in underestimates of k1), it does not affect comparisons across
TetB variants since the host strain remains unchanged. Adding
more parameters to our model, however, could result in an
underdetermined system, leading to the inability to extract signifi-
cant information. The current model recapitulates the most salient
features of the system from the most readily accessible and scal-
able experimental assays.
The present work can be expanded to characterize other MFS
efflux pumps whose substrate is bacteriostatic, allowing for the plot
of steady bacterial growth decrease as a function of substrate
concentration. Although detailed information regarding substrate
diffusion is known for TET, this information should not be neces-
sary for the determination of relative changes of physicochemical
properties within a single substrate. One application for this model
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would be the characterization of other MFS single or multidrug anti-
porters to determine which residues are important for drug binding.
For multidrug transporters, it would be interesting to see if the
residues involved in binding remain the same for all transported
drugs. An additional application is the screening for specific pheno-
types to possibly aid in determining structures for other MFS
transporters. One of the difficulties in determining the structure of
MFS transporters is the potential conformational heterogeneity of
the transporter once purified. Wright and Tate described their char-
acterization of a tet(B) mutant library in search of a variant locked
within a conformation state that has the ability to bind tetracycline
but not efflux it, which may make crystallization and diffraction
less challenging (Wright & Tate, 2015). Our characterization
method can be used to screen through the mutants to reveal which
variant(s) have this desired phenotype. Of our tested mutants, it is
possible that tet(B)G366C would be a good candidate for structural
studies as it binds substrate similar to wild type but has reduced
transport abilities.
Taken together, our work demonstrates that physicochemical
protein properties can be determined from in vivo high-throughput
fitness assays. The success of this model opens the possibility of
characterizing protein libraries and challenging to study proteins in
a rapid timeframe as protein overexpression and purification are not
essential for characterization.
Materials and Methods
Construction of tet(B) expression construct
The pBAD/tet(B)/rrnB/pET28b (+) expression construct was created
using restriction enzyme/ligation cloning within the pET28b (+)
vector (Novagen). Both the pBAD promoter and rrnB terminator
were amplified from the pTARA plasmid, a gift from the Kathleen
Matthews laboratory at Rice University (Wycuff & Matthews, 2000).
Tetracycline efflux pump tet(B) was amplified from a genomic prep
from XL1 Blue Supercompetent cells from Stratagene (Agilent Tech-
nologies, Santa Clara, CA, USA) as these cells naturally harbor the
Tn10 transposon, which contains tet(B). Primer pairs are listed in
Dataset EV1. The genomic prep was performed using the MO BIO
Ultraclean Microbial DNA Extraction Kit (MO BIO, Carlsbad, CA,
USA). A ribosome binding site (RBS) sequence (GAGAGACTCCTC
TCCATAACGAGGCCTATAAAC) was inserted upstream of tet(B).
The RBS sequence was designed with the Salis Lab RBS calculator
and had an arbitrary strength of 20,000 (Salis et al, 2009). Stronger
RBS sequences that induced much greater levels of TetB were found
to also increase fitness costs, and therefore, we decided upon a more
moderate strength for the RBS sequence.
Construction of tet(B) chromosomal variants
TetB variants were created using site-directed mutagenesis
performed on pBAD/tet(B)/rrnB/pET28b (+) template with Phusion
High-Fidelity DNA Polymerase (New England Biolabs). The primer
pairs used for mutagenesis are listed in Dataset EV1. Successful
mutagenesis was confirmed by DNA sequencing. These constructs
were then subcloned into pGRG36 between PacI and XhoI restriction
sites. Insertion was confirmed using colony PCR and sequencing.
Construction of chromosomal insertion strains
Integration of tet(B) and variants into the chromosome of E. coli
strain BW25113 [F-, D(araD-araB)567, DlacZ4787(::rrnB-3),
lambda-, rph-1, D(rhaD-rhaB)568, hsdR514] was performed using
a transposition-based approach that uses Tn7 genes within
pGRG36 to site-specifically insert the pBAD/tet(B)/rrnB construct
into the Tn7 attachment site downstream of the highly conserved
glmS gene following the method described by McKenzie & Craig
(2006). First, tet(B)WT and variant constructs were subcloned from
pET28b(+) into pGRG36. pGRG36 is temperature sensitive and
encodes an ampicillin resistance gene. Once successful transposi-
tion is confirmed, the cells can be cured of pGRG36 by increasing
the growth temperature from 30 to 42°C. Curing was also con-
firmed by replica plating on agar plates containing ampicillin.
Liquid cultures of transposed and cured strains were stored at
80°C in 15% glycerol.
Determination of absolute growth rates for tet(B)
chromosomal strains
Growth rates of E. coli BW25113 cells with and without a chromo-
somal copy of tet(B)WT or variant were performed in non-tissue-
cultured 96-well plate with low evaporation lid (Corning Costar
3595). Glycerol stocks were streaked onto LB-glucose plates where
glucose was used to repress the pBAD promoter and subsequently
expression of tet(B) or variant. Single colonies were grown in
1 ml of 2% arabinose-supplemented LB in a 96-deep well plate for
24 h (1 h) in an orbital shaker at 225 rpm at 37°C. Cultures
were then diluted 1:100 in antibiotic + 2% arabinose-supple-
mented LB media (10 ll culture + 990 ll media); 150 ll of this
mixture then added to a 96-well plate where OD600 was measured
every 5 min for 20–24 h using the Epoch 2 Microplate Reader
(BioTek Instruments).
Membrane preparation to estimate protein concentration
Glycerol stocks of BW25113 cells containing a chromosomal copy of
tet(B)WT or variant were streaked onto glucose-supplemented LB
plates and incubated at 37°C to obtain single colonies. Single colo-
nies were then grown 2% arabinose-supplemented LB for 24 (1 h)
h at 37°C shaking at 225 rpm. Cells were diluted 1:100 in fresh 2%
arabinose-supplemented LB (1.25 ml culture in 125 ml of LB).
Growth was monitored by checking OD600 every 30 min. Once the
cells reached mid-exponential growth phase (approximately OD600
0.4–0.6), 60 ml of the culture was spun down at 4,000 g for 15 min.
The cell pellet was then weighed and stored at 80°C. Bacterial
membranes were prepared by freeze-thawing the cell pellet 3× in
liquid nitrogen/37°C for 10 min followed by resuspension in lysis
buffer to 25 mg/ml [50 mM Tris pH 7.5, 1 M NaCl, 0.3 mM DTT,
0.2 mM PMSF, 20% glycerol, 0.05% Tween 20, and 1× protease
inhibitor (Roche)]. Sonication using a microtip was performed at
60% duty and six output twice for 30 s and then spun at 2,000 g for
15 min to remove cell debris. The supernatant was then spun at
18,000 g for 45 min to pellet the membrane fraction of the cell. The
membrane fraction was then resuspended in lysis buffer to a
concentration of 10 mg/ml and immediately used for Western blot
analysis.
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Determination of protein concentration in membrane
Western blots on bacterial membrane fractions were used to esti-
mate the amount of protein in tet(B) variant constructs relative to
wild type; 45 lg of membrane samples was run on a 10% SDS–
PAGE gel for 1 h. Protein samples were then transferred onto PVDF
membrane for 2 h using a Bio-Rad semidry transfer system and
blocked with 5% non-fat milk in TBST for 1 h. The membrane was
then washed with TBST and incubated overnight with 1:5,000 dilu-
tion of an antibody for the last 15 amino acids on the cytoplasmic C-
terminal tail of TetB (Yamaguchi et al, 1990). The TetB antibody
was created by GenScript using the peptide sequence published by
Yamaguchi et al (LTPQAQGSKQETSA) with the exception that a
cysteine was added to the N-terminal of the peptide to aid in
keyhole limpet hemocyanin (KLH) conjugation. The membrane was
then washed and incubated with 1:5,000 dilution of anti-rabbit
secondary antibody for 90 min (Pierce Antibodies). The membrane
was again washed and imaged using SigmaFast BCIP/NBT tablets.
ImageJ software was used for quantification.
Creation and screening of plasmid tet(B) mutant library
The pBAD-driven tet(B) expression construct in pGRG36 was ampli-
fied and inserted into low-copy-number, ampicillin-resistant plas-
mid pSC101 using restriction ligation cloning in BW25113. Agilent
Gene Morph II EZ Clone Domain Mutagenesis Kit (cat# 200552)
was used to create a low rate, 1–4 mutations/kb, tet(B) mutant
library using 640 ng of target DNA. The primers used for creation
of the library amplified only tet(B) and are listed within Dataset
EV1. The resulting library was transformed into BW25113 using
electroporation and plated on 25 lg/ml TET. The following day,
replica plating was performed on 250 and 300 lg/ml TET to screen
for possible loss- and gain-of-function variants. On a single 96-well
plate, 44 single colonies from the library were further screened
against four WT single colonies by a growth assay at 100 lg/ml.
Seven strains, which had a growth rate different than WT, were
sequenced and further characterized by growth analysis at a wide
range of TET concentrations. Growth rate setup of the plasmid
strains were performed identical to that of the chromosomal strains
with the exception that 100 lg/ml ampicillin was also added to
liquid and agar media to ensure selection of the plasmid backbone
pSC101.
Agar MIC comparison of BW25113 containing chromosomal tet(B)
versus plasmid tet(B)
Agar MIC testing was performed on BW25113 containing pSC101
expressed tet(B) to serve as a metric/guide for replica plating to be
done on the pSC101 expressed tet(B) mutant library. The lowest
concentration of TET that inhibited growth of WT was then used to
for replica plating in an effort to discern between possible gain-of-
function or loss-of-function TetB variants. First, glycerol stocks of
BW25113 expressing tet(B) from the chromosome or pSC101 plas-
mid were streaked onto 0.18% glucose-supplemented LB agar to
repress the pBAD arabinose-inducible promoter. Three single colo-
nies for each strain were then grown for 24 h in 1 ml of 2% arabi-
nose-supplemented LB in a deep well plate; 2 ll of culture was then
spotted onto LB arabinose plates containing 0, 100, 150, 200, 250,
or 300 lg/ml TET and incubated for 24 h at 37°C. The pSC101
expressing tet(B) strain grew at 250 lg/ml but not 300 lg/ml.
Mathematical analysis
All computation and data analyses were done in Matlab R2013b
using custom written code (Code EV1). OD600 data from growth rate
assays were used to compute growth rates for each drug concentra-
tion (Appendix Fig S11). A value of 0.086 was subtracted from all
data points to zero measurements against the OD600 of the media.
The slope of the logarithmically transformed OD600 data at each time
point was approximated using a moving window. Then, we took the
measured slope at the first inflection point of the data as our
measured growth rate. This inflection point appears as a peak in the
first derivative. The parameters used in the analysis where the
window size for averaging and the bin size used in finding the peaks
in the data. Changing the window size and bin size was used to
remove stochasticity in growth and measurement noise. To avoid
bias, the parameters were held constant across replicates. To fit the
models, the data were then normalized by dividing all data points by
the average growth rate at zero drug concentration across the repli-
cates. Parameter fitting was done by minimizing the mean square
error using the Matlab optimization function fmincon (Code EV2).
Determination of error within global parameters A and B
Global parameters A and B are used in downstream analysis of cells
expressing tet(B) leading to a propagation of errors. Figure 1B
shows the fits generated by the model in response to TET, DOX, and
MCN. These are the least squares (LS) fits that correspond to the
mean of the distribution. We consider the range of possible values
of A and B that would fit any combination of the measured growth
rates at each concentration. The growth rate equation (1),
GR ¼ 1 S½ BC
ABþ½SBC
, changes continuously in parameters A and B; there-
fore, we can exploit this fact to reason that the ranges of A and B
can be found by fitting parameters to two sets of data consisting of
the all the maximum and minimum measured growth rates (i.e., the
upper and lower bounds of the data). Table 1 shows the calculated
range of the parameters along with the median found from the range
and the least squares fit for comparison. The median values are
close to the least squares fit values revealing that our distribution is
most likely symmetric. We approximate the distribution of A and B
with a gamma distribution centered at the least squares fit value.
We approximate the standard deviation from the calculated spread.
We assume that the experimental data sets obtained are contained
within one standard deviation of the mean. We assume that not
enough measurements were taken to see data on the outskirts of the
distribution. For our sample size, the predicted standard deviation is
r  (Amax  Amin)/2. We use the results in this section for our
analysis of TetB variants.
Creation of TetB homology model
A theoretical model of the TetB tertiary structure was created using
Phyre2 based upon its sequence homology with the E. coli MFS
transporter YajR (PBD ID: 3wdo; Kelley et al, 2015). YajR was
selected for the homology model due to its high sequence similarity
to TetB (32%) with the resulting model displaying 100% confidence
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according to Phyre2. Based on protein similarity alone, it is believed
that YajR is also a drug:H+ antiporter (Jiang et al, 2013). For the fig-
ures, ribbon diagrams of the model were created using the PyMOL
Molecular Graphics System, version 1.8 Shrӧdinger, LLC.
Expanded View for this article is available online.
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